PhD candidate Favour Akabogu has earned a scholarship and an award to continue research developing new therapies for GIST, a rare type of cancer.

More than 1,330 research projects were submitted to the 2024 AMA Research Challenge for consideration.

Pranoti Mandrekar, PhD, professor of medicine, wrote an article for The Conversation explaining the link between alcohol consumption and cancer risk.

Research by Sharon Cantor, PhD, and Jenna M. Whalen, PhD, poses a new explanation for how cancer-fighting drugs attack and destroy BRCA1 and BRCA2 tumor cells.

William Flavahan, PhD, is one of 40 recipients of the $1.5 million NIH Director’s New Innovator Award, designed to support early career investigators who are proposing bold research.

More than $650,000 was raised for the 26th annual UMass Cancer Walk.

UMass Chan Medical School scientists Marcus Ruscetti, PhD, and Prabhani Atukorale, PhD, have developed a new, dual immunotherapy approach that may potentially change the way clinicians treat pancreatic cancer.  

Research aimed at identifying the mechanisms that promote resistance to radiation therapy in patients with triple negative breast cancer is underway at UMass Chan Medical School by Arthur M. Mercurio, PhD, thanks to a new $2.6 million cancer research award from the National Institutes of Health.

Faculty members from the three UMass Chan graduate schools were honored at the 2024 Educational Recognition Awards ceremony and Susan Zweizig, MD, delivered the annual honorary Last Lecture, titled “What You Don’t See.”

The two UMass Chan faculty members are among 500 scientists, engineers and innovators elected this year.